Dr. Sameer Indravadan Dani is a highly experienced Cardiologist based in Ahmedabad, Gujarat, with an impressive 27 years in the field of medicine. He earned his MBBS, MD, and DM in Cardiology, qualifying him to provide top-notch cardiac care. Dr. Dani is known for his compassionate approach to treatment and patient care, emphasizing the importance of understanding and addressing each patient's individual needs. He is fluent in English, Hindi, and Gujarati, making him accessible to a diverse range of patients. Currently affiliated with Apollo Hospitals, Dr. Dani is committed to staying at the forefront of cardiology, regularly updating his knowledge and skills to provide the best possible outcomes for his patients. His expertise encompasses a wide range of cardiac conditions, and he utilizes advanced diagnostic and treatment techniques to manage heart diseases effectively. As a doctor who genuinely cares, Dr. Dani has garnered a strong reputation in the community, ensuring his patients feel comfortable and informed throughout their treatment journeys. Whether you need a routine check-up or specialized cardiac intervention, Dr. Sameer Indravadan Dani is dedicated to helping you achieve optimal heart health.
- Working in Apollo Hospitals since last Assignment.
- Hon. Cardiologist to H.E. the Governor of Gujarat., Professor & Chief-Dept. of Cardiology - U N Mehta Institute of Cardiology & Research Center and Civil Hospital, Ahmedabad
Awards & Achievements
- Gold Medal winner in Dr. Madanagopal Medal for Medical Gastroenterology prize exam (2005)
- Gold Medal winner in Internal medicine prize exam (2005)
Research & Publications
- First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels - results from the meriT-1 trial. Dani S, Costa RA, Joshi H, Shah J, Pandya R, Virmani R, Sheiban I, Bhatt S, Abizaid A. EuroIntervention; 2013 Aug 22;9(4):493-500.
- Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: 12-month results from the TARGET II trial. Xu B, Zhao Y, Yang Y, Zhang R, Li H, Ma C, Chen S, Wang J, Huo Y, Leon MB, Gao R. Chin Med J (Engl); 2014;127(6):1027-32.
- Comparison of a drug-eluting balloon first and then bare metal stent with a drug-eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial. Park SD, Yoon CH, Oh IY, Suh JW, Cho YS, Youn TJ, Choi DJ, Chae IH. Trials; 2013;14:38.
- Nine-month angiographic and two-year clinical follow-up of polymer-free sirolimus-eluting stent versus durable-polymer sirolimus-eluting stent for coronary artery disease: the Nano randomized trial. Zhang Y, Chen F, Muramatsu T, Xu B, Li Z, Ge J, He Q, Yang Z, Li S, Wang L, Wang H, He B, Li K, Qi G, Li T, Zeng H, Peng J, Jiang T, Zeng Q, Zhu J, Fu G, Bourantas CV, Serruys PW, Huo Y. Chin Med J (Engl); 2014;127(11):2153-8.
- Experience with biodegradable polymer coated sirolimus-eluting coronary stent system in "real-life" percutaneous coronary intervention: 24-month data from the manipal-s registry. Shetty R, Vivek G, Thakkar A, Mishra SS, Joseph V, Devraj MG, Tumkur A, Pai U. J Clin Diagn Res; 2013 Sep;7(9):1959-63.
FAQs
Ask your query
Have a question? Ask your query below.

Best Hospital Near me Chennai